{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:51:09Z","timestamp":1786992669628,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jiac.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:06:48Z","timestamp":1643605608000},"page":"810-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8045-1359","authenticated-orcid":false,"given":"Tatsuya","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2207-4508","authenticated-orcid":false,"given":"Ryo","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-8475","authenticated-orcid":false,"given":"Yoshihiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwao","family":"Gohma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.01.014_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/bjh.15722","article-title":"Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis","volume":"184","author":"Mart\u00ednez-Calle","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2022.01.014_bib2","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","article-title":"Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study","volume":"27","author":"Lamure","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jiac.2022.01.014_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS- CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2022.01.014_bib4","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2022.01.014_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jiac.2020.12.001","article-title":"Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient","volume":"27","author":"Nakajima","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.01.014_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10147-020-01837-0","article-title":"Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan","volume":"26","author":"Nakamura","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jiac.2022.01.014_bib7","first-page":"1867","article-title":"Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma","volume":"91","author":"Levi","year":"2021","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.jiac.2022.01.014_bib8","doi-asserted-by":"crossref","first-page":"613502","DOI":"10.3389\/fimmu.2021.613502","article-title":"Case report: stepwise anti-inflammatory and anti-SARS-CoV-2 effects following convalescent plasma therapy with full clinical recovery","volume":"12","author":"Zimmerli","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2022.01.014_bib9","first-page":"1","article-title":"Clinical characteristics and risk factors associated with nosocomial COVID\u201019 infection in patients with hematological disorders in Japan","author":"Ohara","year":"2021","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jiac.2022.01.014_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/bjh.15722","article-title":"Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis","author":"OMartinez-Calle","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2022.01.014_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2014.11.009","article-title":"Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease","author":"Robers","year":"2015","journal-title":"J Autoimmunity"},{"key":"10.1016\/j.jiac.2022.01.014_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jiac.2022.01.014_bib13","first-page":"159","article-title":"COVID-19 recovery without B cells or antibodies in patients receiving rituximab for autoimmune disease","volume":"1","author":"Zonozi","year":"2021","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.jiac.2022.01.014_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/thoraxjnl-2020-216088","article-title":"Severe organizing pneumonia following COVID -19","volume":"76","author":"Vad\u00e1sz","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2022.01.014_bib15","first-page":"ciab721","article-title":"Clinical and virological features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)","author":"Ong","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:13Z","timestamp":1761159853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1341321X22000277"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.01.014","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}